(Q44667862)

5 December 2017

Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats (English)

1 reference

5 December 2017

1 reference

1 reference

3

1 reference

5 December 2017

Heller J

1

1 reference

5 December 2017

Shiozawa T

2

1 reference

5 December 2017

Hennenberg M

4

1 reference

5 December 2017

Schepke M

5

1 reference

5 December 2017

Neef M

6

1 reference

5 December 2017

Sauerbruch T

7

1 reference

5 December 2017

1 November 2003

1 reference

European Journal of Clinical Investigation

5 December 2017

1 reference

5 December 2017

33

1 reference

5 December 2017

11

1 reference

5 December 2017

1006-1012

1 reference

Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension

5 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.2003.01251.X

10.1046/J.1365-2362.2003.01251.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference